Egetis Therapeutics Launches Educational Websites on MCT8 Deficiency for Physicians and Caregivers

STOCKHOLM, SWEDEN / ACCESS Newswire / March 2, 2026 / Egetis Therapeutics AB (publ) ("Egetis" or the "Company") (NASDAQ Stockholm:EGTX), today announced the launch of two updated educational websites focused on MCT8 deficiency for audiences across …